Episode 823
Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University, a leading scientist in the development and degeneration of the visual system from eye to brain, and a practicing ophthalmologist and surgeon.
This episode is brought to you by:
Gamma AI design partner for effortless presentations, websites, social media posts, and more: https://gamma.app (Use code TIM at checkout for 30% off any plan.)
Helix Sleep premium mattresses: https://HelixSleep.com/Tim (27% off on all mattress orders.)
AG1 all-in-one nutritional supplement: https://DrinkAG1.com/Tim (1-year supply of Vitamin D plus 5 free AG1 travel packs with your first subscription purchase.)
Timestamps:
[00:00:00] Start.
[00:05:30] How do you solve a problem like presbyopia?
[00:08:34] The athletic benefits of training supranormal (better than 20/20) vision.
[00:11:49] Indigenous eye drops and FDA-approved pilocarpine for presbyopia.
[00:14:05] Understanding basic eye anatomy.
[00:17:27] Exploring AREDS 2, CoQ10, ginkgo, vitamin B3, and other supplements for vision.
[00:23:00] Visual training devices and psychedelic-prompted brain plasticity.
[00:25:12] Thoughts on visual training effectiveness and motor action requirements.
[00:28:29] Concussion rehabilitation and visual perception exercises.
[00:32:36] Red light and violet light therapy for myopia and mitochondrial health.
[00:36:07] Vision loss correlation with cognitive decline and depression.
[00:39:36] Presbyopia progression and psychological dependence on readers.
[00:41:15] Cognito Therapeutics headset for Alzheimer's treatment.
[00:46:46] Glaucoma basics: neurodegenerative disease and risk factors.
[00:48:53] Eye pressure variability and diurnal cycles.
[00:50:02] Cannabis effects on eye pressure and compound isolation.
[00:51:47] Stem cell research for vision restoration.
[00:53:09] Anti-inflammatory effects and immune system role in eye diseases.
[00:55:15] Gut microbiome connection to glaucoma in animal models.
[00:58:43] Metabolic syndrome and GLP-1 receptor agonists.
[01:00:50] Microbiome sharing and future therapeutic possibilities.
[01:03:31] Dry eye treatment: preservative-free tears and serum drops.
[01:08:43] Vision screening recommendations and UV protection.
[01:11:22] Full-spectrum light benefits vs. UV exposure.
[01:13:27] Paradigm shifts: irreversible vision loss becoming reversible.
[01:17:18] Convergence of neuroscience advances and biotech investment.
[01:21:58] Miraculous mitochondria: health, transplants, and three-parent babies.
[01:26:24] My family history concerns and metabolic health screening.
[01:29:26] Exercise's biggest gain: going from none to some.
[01:33:03] Clinical trial participation resources and parting thoughts.
*
For show notes and past guests on The Tim Ferriss Show, please visit Published on 1 month, 2 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate